P-0180 - Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC – Efficacy and Safety

Autor: Sasa, Jungic, Gordana, Kecman Malcic, Ivanka, Rakita, Dusan, Jovanovic, Radoslav, Gajanin, Zdravko, Maric, Biljana, Tubic, Zdenka, Gojkovic
Zdroj: In Annals of Oncology June 2014 25 Supplement 2:ii68-ii68
Databáze: ScienceDirect